We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

329 hedge funds and large institutions have $2.96B invested in Sabra Healthcare REIT in 2023 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 106 increasing their positions, 108 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more call options, than puts

Call options by funds: $3.08M | Put options by funds: $1.82M

24% more capital invested

Capital invested by funds: $2.38B → $2.96B (+$577M)

23% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 39

4.25% more ownership

Funds ownership: 87.54%91.78% (+4.2%)

1% more funds holding

Funds holding: 325329 (+4)

2% less repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 108

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
329
Holders Change
+4
Holders Change %
+1.23%
% of All Funds
5.22%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
48
Increased
106
Reduced
108
Closed
39
Calls
$3.08M
Puts
$1.82M
Net Calls
+$1.26M
Net Calls Change
+$1.09M
Name Holding Trade Value Shares
Change
Change in
Stake
PWMG
326
Provence Wealth Management Group
California
$153 +$141 +11 New
ECM
327
Estabrook Capital Management
New York
$14
CIM
328
Centersquare Investment Management
Pennsylvania
-$32.2M -2,739,622 Closed
Point72 Asset Management
329
Point72 Asset Management
Connecticut
-$11.3M -958,354 Closed
MPM
330
Mountaineer Partners Management
New York
-$10.1M -860,208 Closed
AM
331
AGF Management
Ontario, Canada
-$3.87M -329,022 Closed
LIP
332
Lighthouse Investment Partners
Florida
-$2.65M -225,000 Closed
Holocene Advisors
333
Holocene Advisors
New York
-$2.28M -193,483 Closed
Axa
334
Axa
France
-$2.03M -172,575 Closed
Marshall Wace
335
Marshall Wace
United Kingdom
-$1.84M -156,014 Closed
Bank of Nova Scotia
336
Bank of Nova Scotia
Ontario, Canada
-$514K -43,662 Closed
VLKIM
337
Van Lanschot Kempen Investment Management
Netherlands
-$354K -30,100 Closed
YIH
338
Y-Intercept (HK)
Hong Kong
-$260K -22,095 Closed
VF
339
Virtu Financial
New York
-$253K -21,486 Closed
KAS
340
Kestra Advisory Services
Texas
-$253K -21,454 Closed
AI
341
AXS Investments
New York
-$252K -21,383 Closed
PI
342
PEAK6 Investments
Illinois
-$266K -20,811 Closed
AWS
343
Atria Wealth Solutions
New York
-$245K -20,788 Closed
Squarepoint
344
Squarepoint
New York
-$228K -19,364 Closed
WAM
345
Weiss Asset Management
Massachusetts
-$197K -16,769 Closed
VIA
346
Vident Investment Advisory
Georgia
-$196K -16,628 Closed
VAS
347
Vestmark Advisory Solutions
Massachusetts
-$178K -15,084 Closed
GLA
348
Great Lakes Advisors
Illinois
-$175K -14,841 Closed
RJA
349
Raymond James & Associates
Florida
-$164K -13,908 Closed
Wolverine Trading
350
Wolverine Trading
Illinois
-$165K -13,843 Closed

SBRA Hedge Fund Activity: Q3 2023 in Review

329 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q3 2023, worth a combined $2.96B — up 24% from $2.38B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new SBRA positions and 39 closed out — a net gain of 9 holders — while 106 added to existing stakes and 108 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $151M. The largest seller was Centersquare Investment Management, exiting entirely with an estimated $32.2M sold.

  • 329 institutional investors held Sabra Healthcare REIT (SBRA) as of Q3 2023, up from 325 in Q2 2023.
  • Funds reported $2.96B of Sabra Healthcare REIT stock for Q3 2023, up 24% quarter-over-quarter.
  • 48 funds opened new Sabra Healthcare REIT positions in Q3 2023 and 39 closed out, a net change of +9 holders.
  • The largest Sabra Healthcare REIT buyer in Q3 2023 was JP Morgan Chase, an estimated $151M added.
  • The largest Sabra Healthcare REIT seller in Q3 2023 was Centersquare Investment Management, an estimated $32.2M sold.

Based on aggregated 13F filings for Q3 2023.